Maskarinec Gertraud, Nakamura Kaylae L, Woolcott Christy G, Conroy Shannon M, Byrne Celia, Nagata Chisato, Ursin Giske, Vachon Celine M
University of Hawaii Cancer Center, 701 Ilalo Street, Honolulu, HI, 96813, USA,
Cancer Causes Control. 2015 Apr;26(4):621-6. doi: 10.1007/s10552-015-0551-2. Epub 2015 Mar 12.
Mammographic density, i.e., the radiographic appearance of the breast, is a strong predictor of breast cancer risk. To determine whether the association of breast density with breast cancer is modified by a first-degree family history of breast cancer (FHBC) in women of white and Asian ancestry, we analyzed data from four case-control studies conducted in the USA and Japan.
The study population included 1,699 breast cancer cases and 2,422 controls, of whom 45% reported white (N = 1,849) and 40% Asian (N = 1,633) ancestry. To standardize mammographic density assessment, a single observer re-read all mammograms using one type of interactive thresholding software. Logistic regression was applied to estimate odds ratios (OR) while adjusting for confounders.
Overall, 496 (12%) of participants reported a FHBC, which was significantly associated with breast cancer risk in the adjusted model (OR 1.51; 95% CI 1.23-1.84). There was a statistically significant interaction on a multiplicative scale between FHBC and continuous percent density (per 10 % density: p = 0.03). The OR per 10% increase in percent density was higher among women with a FHBC (OR 1.30; 95% CI 1.13-1.49) than among those without a FHBC (OR 1.14; 1.09-1.20). This pattern was apparent in whites and Asians. The respective ORs were 1.45 (95% CI 1.17-1.80) versus 1.22 (95% CI 1.14-1.32) in whites, whereas the values in Asians were only 1.24 (95% CI 0.97-1.58) versus 1.09 (95% CI 1.00-1.19).
These findings support the hypothesis that women with a FHBC appear to have a higher risk of breast cancer associated with percent mammographic density than women without a FHBC.
乳腺钼靶密度,即乳房的影像学表现,是乳腺癌风险的一个强有力的预测指标。为了确定在白种人和亚洲血统女性中,乳腺癌家族史(FHBC)是否会改变乳腺密度与乳腺癌之间的关联,我们分析了在美国和日本进行的四项病例对照研究的数据。
研究人群包括1699例乳腺癌病例和2422例对照,其中45%报告为白种人(N = 1849),40%为亚洲人(N = 1633)。为了标准化乳腺钼靶密度评估,由一名观察者使用一种交互式阈值软件重新阅读所有乳房X光片。应用逻辑回归来估计比值比(OR),同时对混杂因素进行调整。
总体而言,496名(12%)参与者报告有FHBC,在调整模型中,这与乳腺癌风险显著相关(OR 1.51;95%CI 1.23 - 1.84)。FHBC与连续百分比密度之间在相乘尺度上存在统计学显著的交互作用(每10%密度:p = 0.03)。有FHBC的女性中,百分比密度每增加10%的OR(OR 1.30;95%CI 1.13 - 1.49)高于无FHBC的女性(OR 1.14;1.09 - 1.20)。这种模式在白种人和亚洲人中都很明显。白种人中各自的OR为1.45(95%CI 1.17 - 1.80)对1.22(95%CI 1.14 - 1.32),而亚洲人中的值仅为1.24(95%CI 0.97 - 1.58)对1.09(95%CI 1.00 - 1.19)。
这些发现支持了这样的假设,即与无FHBC的女性相比,有FHBC的女性因乳腺钼靶密度百分比而患乳腺癌的风险似乎更高。